CorMedix Inc. (CRMD)
Pharmaceutical Preparations
Latest Price
$7.53
TTM P/E
3.47
Normalized P/E
397.42
Div Yield
--
Book Value
5.50
P/B Ratio
1.37
Valuation metrics
adjust assumptions →EPS: $2.04
Book value / share: $5.11
Formula: √(22.5 × EPS × BVPS)
Graham Number
$15.32
+103% upside
EPS: $2.04
Target P/E: 3×
Formula: EPS × P/E
P/E Fair Value
$6.12
19% downside
Institutional Ownership
52.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 6.27M | $42.0M | 8.00% | +1.00M | 2026-03-31 |
| BlackRock, Inc. | 5.97M | $40.0M | 7.61% | +191.1K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.13M | $21.0M | 3.99% | -- | 2026-03-31 |
| STATE STREET CORP | 2.19M | $14.0M | 2.80% | +271.0K | 2026-03-31 |
| ROYCE & ASSOCIATES LP | 1.89M | $12.0M | 2.41% | +1.65M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.82M | $12.0M | 2.32% | -95.3K | 2026-03-31 |
| UBS Group AG | 1.54M | $10.0M | 1.96% | +902.2K | 2026-03-31 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.21M | $8.0M | 1.54% | +406.0K | 2026-03-31 |
| Alyeska Investment Group, L.P. | 850.0K | $5.0M | 1.08% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 742.6K | $5.0M | 0.95% | -- | 2026-03-31 |